Joanna Wietrzyk Selected Research

Calcitriol (Calcijex)

4/2022	Micro-RNAs in Response to Active Forms of Vitamin D3 in Human Leukemia and Lymphoma Cells.
1/2022	Polymorphism of VDR Gene and the Sensitivity of Human Leukemia and Lymphoma Cells to Active Forms of Vitamin D.
3/2021	Vitamin D Compounds PRI-2191 and PRI-2205 Enhance Anastrozole Activity in Human Breast Cancer Models.
11/2020	Calcitriol in the Presence of Conditioned Media from Metastatic Breast Cancer Cells Enhances Ex Vivo Polarization of M2 Alternative Murine Bone Marrow-Derived Macrophages.
11/2020	Vitamin D Metabolite Profile in Cholecalciferol- or Calcitriol-Supplemented Healthy and Mammary Gland Tumor-Bearing Mice.
9/2020	Differential Impact of Calcitriol and Its Analogs on Tumor Stroma in Young and Aged Ovariectomized Mice Bearing 4T1 Mammary Gland Cancer.
4/2020	Divergent Effect of Tacalcitol (PRI-2191) on Th17 Cells in 4T1 Tumor Bearing Young and Old Ovariectomized Mice.
10/2019	Calcitriol Analogues Decrease Lung Metastasis but Impair Bone Metabolism in Aged Ovariectomized Mice Bearing 4T1 Mammary Gland Tumours.
1/2019	Steroid hormone calcitriol and its analog tacalcitol inhibit miR-125b expression in a human breast cancer MCF-7 cell line.
7/2018	Calcitriol and Its Analogs Establish the Immunosuppressive Microenvironment That Drives Metastasis in 4T1 Mouse Mammary Gland Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joanna Wietrzyk Research Topics

Disease

135	Neoplasms (Cancer) 06/2022 - 01/2003
36	Breast Neoplasms (Breast Cancer) 06/2022 - 02/2004
26	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2003
25	Leukemia 04/2022 - 01/2007
20	Neoplasm Metastasis (Metastasis) 11/2020 - 01/2003
13	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2007
6	Melanoma (Melanoma, Malignant) 03/2019 - 01/2009
4	Lymphoma (Lymphomas) 04/2022 - 11/2016
4	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2019
4	Adenocarcinoma of Lung 01/2020 - 12/2014
4	Prostatic Neoplasms (Prostate Cancer) 07/2019 - 04/2013
3	Carcinoma (Carcinomatosis) 01/2021 - 11/2004
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2018 - 05/2014
3	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 05/2016
3	Bacterial Infections (Bacterial Infection) 04/2013 - 06/2009
2	Carcinogenesis 06/2022 - 05/2005
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2022 - 08/2018
2	Gout 01/2021 - 11/2018
2	Adenocarcinoma 12/2019 - 03/2019
2	Osteoporosis 10/2019 - 01/2018
2	Leukemia P388 01/2017 - 04/2013
2	Experimental Melanoma 11/2012 - 06/2007
2	Infections 06/2009 - 02/2003

Drug/Important Bio-Agent (IBA)

20	Pharmaceutical PreparationsIBA 04/2022 - 10/2010
20	Calcitriol (Calcijex)FDA LinkGeneric 04/2022 - 09/2004
18	1 alpha,24-dihydroxyvitamin D3 (Tacalcitol)IBA 04/2022 - 09/2004
17	Vitamin D FDA LinkGeneric 04/2022 - 01/2007
16	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 09/2004
13	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 09/2007
10	calcipotriene (calcipotriol)FDA LinkGeneric 03/2021 - 04/2007
10	Cytostatic AgentsIBA 12/2020 - 01/2007
9	Proteins (Proteins, Gene)FDA Link 06/2022 - 06/2007
9	Biological ProductsIBA 01/2021 - 02/2004
8	Colchicine FDA LinkGeneric 04/2021 - 11/2018
8	AcidsIBA 12/2020 - 09/2013
7	Calcitriol Receptors (Calcitriol Receptor)IBA 04/2022 - 01/2007
7	salinomycinIBA 12/2020 - 12/2012
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2019 - 11/2004
6	Hormones (Hormone)IBA 06/2022 - 11/2004
5	Cholecalciferol (Vitamin D3)FDA Link 04/2022 - 01/2007
5	Therapeutic UsesIBA 03/2021 - 09/2007
5	DNA (Deoxyribonucleic Acid)IBA 08/2020 - 05/2002
5	LigandsIBA 01/2020 - 02/2010
5	Anti-Bacterial Agents (Antibiotics)IBA 09/2013 - 02/2003
4	xanthohumolIBA 12/2019 - 04/2013
4	Docetaxel (Taxotere)FDA Link 11/2019 - 01/2012
4	Fluorouracil (Carac)FDA LinkGeneric 11/2019 - 06/2013
4	EstersIBA 10/2019 - 04/2013
4	betulinIBA 01/2019 - 04/2013
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2018 - 11/2015
3	Estrogens (Estrogen)FDA Link 03/2021 - 02/2004
3	EnzymesIBA 03/2021 - 03/2003
3	ThiazolesIBA 01/2021 - 01/2014
3	Antimitotic AgentsIBA 01/2021 - 11/2018
3	Monensin (Coban)IBA 12/2020 - 10/2015
3	Caspase 3 (Caspase-3)IBA 10/2020 - 01/2019
3	IntegrinsIBA 10/2020 - 10/2008
3	1,25-dihydroxyergocalciferolIBA 01/2020 - 10/2008
3	neocryptolepineIBA 06/2019 - 05/2014
3	Fibrinogen (Factor I)FDA Link 01/2019 - 01/2018
3	Clopidogrel (Plavix)FDA Link 11/2018 - 01/2017
3	Phosphatidylcholines (Phosphatidylcholine)IBA 10/2018 - 01/2017
3	AmidesIBA 08/2018 - 05/2004
3	Imatinib Mesylate (Gleevec)FDA Link 02/2018 - 01/2012
3	GenisteinIBA 01/2011 - 02/2004
2	IsomerasesIBA 06/2022 - 10/2020
2	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2022 - 11/2020
2	Histone Deacetylases (Histone Deacetylase)IBA 08/2021 - 01/2016
2	Urea (Carbamide)FDA LinkGeneric 01/2021 - 01/2017
2	LasalocidIBA 12/2020 - 09/2013
2	Fibronectins (Fibronectin)IBA 10/2020 - 01/2009
2	chrysinIBA 01/2020 - 01/2018
2	FlavonoidsIBA 01/2020 - 11/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2019 - 02/2013
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2019 - 02/2013
2	NitrogenIBA 10/2019 - 10/2012
2	LactonesIBA 10/2019 - 04/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2019 - 01/2018
2	IsothiocyanatesIBA 08/2019 - 08/2011
2	SteroidsIBA 01/2019 - 05/2005
2	1- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazeneIBA 01/2019 - 11/2018
2	isoxanthohumolIBA 11/2018 - 01/2017
2	Antineoplastic Agents (Antineoplastics)IBA 11/2018 - 01/2017
2	Phospholipids (Phosphatides)FDA LinkGeneric 10/2018 - 01/2016
2	IonophoresIBA 08/2018 - 10/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 05/2016
2	AnthracyclinesIBA 12/2017 - 05/2006
2	PlatinumIBA 01/2017 - 12/2014
2	N(1)-methylnicotinamideIBA 01/2017 - 01/2016
2	matrigelIBA 01/2016 - 01/2009
2	Surface Antigens (Surface Antigen)IBA 01/2016 - 01/2014
2	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 11/2015 - 01/2007
2	Amino Acids FDA Link 09/2015 - 05/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2015 - 11/2013
2	AminesIBA 12/2012 - 08/2012
2	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2010 - 03/2007
2	daunosamineIBA 03/2007 - 05/2006

Therapy/Procedure

25	Therapeutics 06/2022 - 03/2003
6	Drug Therapy (Chemotherapy) 01/2021 - 01/2007
2	Aftercare (After-Treatment) 08/2018 - 08/2014